Search the collections
Vial - Drug, Tryparsamide (Sodium N-phenylglycineamide-p-arsonate), May & Baker, circa 1930 Reg. No: HT 11785 1
- Vial for drug Tryparsamide. Made by Pharmaceutical Specialties [May & Baker] Ltd., Dagenham, England, circa 1930, by arrangement with the Rockefeller Institute for Medical Research. Kept in a mental health hospital pharmacy and administered to patients at a mental health hospital in Victoria, Australia.
Tryparsamide (trade name) is sodium N-phenylglycineamide-p-arsonate, a compound containing 25% arsenic. Used in conjunction with malarial fever therapy to treat tertiary neuro-syphilis in patients diagnosed with General Paralysis of the Insane (GPI), having been originally developed for the treatment of human African trypanosomiasis, or African sleeping sickness. GPI was found to be caused by the spirochaete bacterium Treponema pallidum and later treated effectively with penicillin.
- 3gm glass vial, sealed. The text on the inner vial is incomplete. The numeral 3 can be made out, followed by the word TRYPARSAMIDE and the May & Baker brand label.
- Acquisition Information:
- Donation from Office of Psychiatric Services
|Dimensions:||7.00 cm (Height), 1.70 cm (Width)|
|Tagged with:||mental health, mental health institutions, psychiatric hospitals, psychiatric services, pharmaceuticals, syphilis, medicines, hospitals, sexually transmitted diseases stds, packaging, psychiatric institutions, medicinals drugs, drugs, diseases, making history - psych services|
|Themes this item is part of:||Medicine in Society Collection, Psychiatric Services Collection, Public Life & Institutions Collection|
|Primary Classification:||MEDICINE & HEALTH|
|Secondary Classification:||Mental Health - Pharmacy|
|Inscriptions:||3/ 07/ TRYPARSAMIDE|
|Manufacturer:||May & Baker Ltd, Dagenham, Essex, England, Great Britain, Circa 1930|
|Place Made:||Rockefeller Institute of Medical Research, New York, New York State, United States of America, Circa 1930|
|Place Used:||Victoria, Australia, Circa 1930|